Cargando…
Immunohistochemical localization of d‐β‐aspartic acid in congenital and acquired middle ear cholesteatoma
OBJECTIVE/HYPOTHESIS: Middle ear cholesteatoma is characterized by abnormal growth of the keratinizing squamous epithelium of the temporal bone. d‐β‐aspartic acid is the major isomer of d‐aspartic acid found in elderly tissue. We assessed the immunoreactivity to k‐β‐aspartic acid of congenital and a...
Autores principales: | Kitaya, Shiori, Ikeda, Ryoukichi, Suzuki, Jun, Oshima, Hidetoshi, Nomura, Yuri, Kusano, Yusuke, Ohta, Nobuo, Kawase, Tetsuaki, Ise, Kazue, Murakami, Kazuhiro, Nakamura, Yasuhiro, Sasano, Hironobu, Katori, Yukio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392411/ https://www.ncbi.nlm.nih.gov/pubmed/36000040 http://dx.doi.org/10.1002/lio2.856 |
Ejemplares similares
-
Use of artificial intelligence for the diagnosis of cholesteatoma
por: Tseng, Christopher C., et al.
Publicado: (2023) -
Immunohistochemical localization of OCT2 in the cochlea of various species
por: Hellberg, Victoria, et al.
Publicado: (2015) -
Incidence and trends of middle ear cholesteatoma surgery and mastoidectomy in Australia—A national hospital morbidity database analysis
por: Li, Jonathan, et al.
Publicado: (2021) -
Outpatient management of cholesteatoma with canal wall reconstruction tympanomastoidectomy
por: Kao, Richard, et al.
Publicado: (2017) -
Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study
por: Samy, Ravi N., et al.
Publicado: (2019)